Dr. Kerry Lainof, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd Ste 1b16, Offutt A F B, NE 68113 Phone: 402-294-6077 |
News Archive
Boston Scientific Corporation today announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the Palmaz-NIR suit. All the disputes involved intellectual property in the interventional cardiology arena. In connection with the settlement, Boston Scientific will make a payment of $716 million to Johnson & Johnson. The settlement payment is within Boston Scientific's existing reserve for the Palmaz-NIR suit and will be made from existing cash on hand.
Skoltech researchers and their colleagues from Russia and Germany have designed an on-chip printed 'electronic nose' that serves as a proof of concept for low-cost and sensitive devices to be used in portable electronics and healthcare.
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection.
"Childhood vaccination represents one of the most successful public health interventions ever," write Matthew M. Davis, M.D., M.A.P.P., of the University of Michigan, Ann Arbor, and Samir S. Shah, M.D., M.S.C.E., of The Children's Hospital of Philadelphia, in an editorial in the May issue of Archives of Pediatrics & Adolescent Medicine, a theme issue on vaccines. "Diseases that once killed thousands of children each year have been virtually eliminated."
› Verified 5 days ago